Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective
Author:
Affiliation:
1. Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.
Funder
Medical Research Council
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01492
Reference155 articles.
1. Signalling through the lipid products of phosphoinositide-3-OH kinase
2. PI3K and cancer: lessons, challenges and opportunities
3. Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
4. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
5. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of PTEN in Chemoresistance Mediated by the HIF-1α/YY1 Axis in Pediatric Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-07-16
2. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023);Journal of Medicinal Chemistry;2024-07-12
3. The role of the methoxy group in approved drugs;European Journal of Medicinal Chemistry;2024-07
4. Synthesis of quinazolinone derivatives with a seven‐membered ring using borrowing hydrogen methodology;Tetrahedron Letters;2024-07
5. Discovery of Novel Azaindoles as Potent and Selective PI3Kδ Inhibitors for Treatment of Multiple Sclerosis;Journal of Medicinal Chemistry;2024-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3